Cargando…
Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation
Gut microbiota dysbiosis is associated with inflammatory bowel diseases and with cardiometabolic, neurological, and autoimmune diseases. Gut microbiota composition has a direct effect on the immune system, and vice versa, and it has a particular effect on Treg homeostasis. Low-dose IL-2 (IL-2(LD)) s...
Autores principales: | Tchitchek, Nicolas, Nguekap Tchoumba, Otriv, Pires, Gabriel, Dandou, Sarah, Campagne, Julien, Churlaud, Guillaume, Fourcade, Gwladys, Hoffmann, Thomas W., Strozzi, Francesco, Gaal, Camille, Bonny, Christophe, Le Chatelier, Emmanuelle, Erlich, Stanislav Dusko, Sokol, Harry, Klatzmann, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536277/ https://www.ncbi.nlm.nih.gov/pubmed/35917175 http://dx.doi.org/10.1172/jci.insight.159406 |
Ejemplares similares
-
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
por: Monsel, Antoine, et al.
Publicado: (2022) -
Long-term diosmectite use does not alter the gut microbiota in adults with chronic diarrhea
por: Da Silva, Kévin, et al.
Publicado: (2022) -
Tolerogenic Dendritic Cells Shape a Transmissible Gut Microbiota That Protects From Metabolic Diseases
por: Lécuyer, Emelyne, et al.
Publicado: (2021) -
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
por: Wen, Chengping, et al.
Publicado: (2017) -
Dietary modulation of the gut microbiota – a randomised controlled trial in
obese postmenopausal women
por: Brahe, Lena K., et al.
Publicado: (2015)